Autoimmune Hepatitis Deteriorated by Anastrozole, an Aromatase Inhibitor, for Breast Cancer Adjuvant Chemotherapy

Acta Hepatologica Japonica - Japan
doi 10.2957/kanzo.55.122
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Japan Society of Hepatology

Related search

Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women

Nowotwory
Cancer ResearchOncology
2019English

Progress in Adjuvant Chemotherapy for Breast Cancer: An Overview

BMC Medicine
Medicine
2015English

Adjuvant Chemotherapy for Early Breast Cancer.

BMJ
1983English

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Breast Care
SurgeryOncology
2010English

Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2015English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

New England Journal of Medicine
Medicine
2005English

Irreversible Heart Failure Related to Adjuvant Anastrozole in a Patient With Breast Cancer

Akdeniz Medical Journal
2017English

Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index

British Journal of Cancer
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy